Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review

References

• Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133:377–85.
   PubMed Web of Science ®Google Scholar
• Gold LS, Corvari L. The roles of safety and compliance in determining effectiveness of topical therapy for psoriasis. Cutis. 2007;79:32–8.
   PubMed Web of Science ®Google Scholar
• Mason A, Mason J, Cork M, et al. Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review. J Am Acad Dermatol. 2013;69:799–807.
   PubMed Web of Science ®Google Scholar
• Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses’ Health Study II. Arch Intern Med. 2007;167:1670–5.
   PubMed Web of Science ®Google Scholar
• Love TJ, Qureshi AA, Karlson EW, et al. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003–2006. Arch Dermatol. 2011;147:419–24.
   PubMed Web of Science ®Google Scholar
• Ahlehoff O, Gislason GH, Charlot M, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2011;270:147–57.
   PubMed Web of Science ®Google Scholar
• Ahlehoff O, Gislason GH, Lindhardsen J, et al. Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study. PLoS One. 2011;6:e18125.
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Choi HK, Setty AR, Curhan GC. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009;145:379–82.
   PubMed Web of Science ®Google Scholar
• Ahlehoff O, Skov L, Gislason G, et al. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. J Eur Acad Dermatol Venereol. 2015;29:1128–34.
   PubMed Web of Science ®Google Scholar
• Warren RB, Kleyn CE, Gulliver WP. Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course. Br J Dermatol. 2011;164:1–14.
   PubMed Web of Science ®Google Scholar
• Vanderpuye-Orgle J, Zhao Y, Lu J, et al. Evaluating the economic burden of psoriasis in the United States. J Am Acad Dermatol. 2015;72:961–7.e5.
   PubMed Web of Science ®Google Scholar
• Schaefer CP, Cappelleri JC, Cheng R, et al. Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States. J Am Acad Dermatol. 2015;73:585–93.e3.
   PubMed Web of Science ®Google Scholar
• Callis Duffin K, Wan J, Troxel AB, et al. Treatment satisfaction with commonly used treatments for moderate to severe plaque psoriasis in clinical practice. J Invest Dermatol. 2012;132:S38.
   Web of Science ®Google Scholar
• Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, et al. Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries. Acta Derm Venereol. 2013;93:442–5.
   PubMed Web of Science ®Google Scholar
• Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27–33.
   PubMed Web of Science ®Google Scholar
• Urquhart J. The odds of the three nons when an aptly prescribed medicine isn’t working: non-compliance, non-absorption, non-response. Br J Clin Pharmacol. 2002;54:212–20.
   PubMed Web of Science ®Google Scholar
• Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clinic Proc. 2011;86:304–14.
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705.
   PubMed Web of Science ®Google Scholar
• Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;11:CD000011.
   PubMed Web of Science ®Google Scholar
• Sabaté E. Adherence to Long-term Therapies: Evidence for Action. WHO/MNC/03.01. Geneva, Switzerland: World Health Organization, 2003.
   Google Scholar
• Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:91.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.
   PubMed Web of Science ®Google Scholar
• Thorneloe RJ, Bundy C, Griffiths CEM, et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol. 2013;168:20–31.
   PubMed Web of Science ®Google Scholar
• Devaux S, Castela A, Archier E, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26:61–7.
   PubMed Web of Science ®Google Scholar
• Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.
   PubMed Web of Science ®Google Scholar
• Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009;62:1013–20.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495–9.
   PubMed Web of Science ®Google Scholar
• NICE: the guidelines manual: appendices B-I. 2012. Available from: http://publications.nice.org.uk/the-guidelines-manual-appendices-bi-pmg6b/appendix-h-methodology-checklist-qualitative-studies#close. Accessed November 30, 2012.
   Google Scholar
• Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140:408–14.
   PubMed Web of Science ®Google Scholar
• Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55:607–13.
   PubMed Web of Science ®Google Scholar
• Storm A, Benfeldt E, Andersen SE, Serup J. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol. 2008;59:975–80.
   PubMed Web of Science ®Google Scholar
• Ersser SJ, Cowdell FC, Latter SM, Healy E. Self-management experiences in adults with mild-moderate psoriasis: an exploratory study and implications for improved support. Br J Dermatol. 2010;163:1044–9.
   PubMed Web of Science ®Google Scholar
• Feldman SR. Disease burden and treatment adherence in psoriasis patients. Cutis 2013;92:258–63.
   PubMed Web of Science ®Google Scholar
• Chan SA, Hussain F, Lawson LG, Ormerod AD. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities. J Dermatol Treat. 2013;24:64–9.
   PubMed Web of Science ®Google Scholar
• Bewley A, Burrage DM, Ersser SJ, et al. Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study. J Eur Acad Dermatol Venereol. 2014;28:763–70.
   PubMed Web of Science ®Google Scholar
• Svedbom A, Dalen J, Mamolo C, et al. Treatment patterns with topicals, traditional systemics and biologics in psoriasis – a Swedish database analysis. J Eur Acad Dermatol Venereol. 2015;29:215–23.
   PubMed Web of Science ®Google Scholar
• Saeki H, Imafuku S, Abe M, et al. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol. 2015;42:367–72.
   PubMed Web of Science ®Google Scholar
• Burroni AG, Fassino M, Torti A, Visentin E. How do disease perception, treatment features, and dermatologist-patient relationship impact on patients assuming topical treatment? An Italian survey. Patient Relat Outcome Meas. 2015;6:9–17.
   PubMedGoogle Scholar
• de Korte J, Van Onselen J, Kownacki S, et al. Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme. J Eur Acad Dermatol Venereol. 2005;19:35–41.
   PubMed Web of Science ®Google Scholar
• Turner RM, Bird SM, Higgins JP. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One 2013;8:e59202.
   PubMed Web of Science ®Google Scholar
• Saveleva E, Selinski S. Meta-analyses with binary outcomes: how many studies need to be omitted to detect a publication bias? J Toxicol Env Health A 2008;71:845–50.
   PubMed Web of Science ®Google Scholar
• Furue M, Onozuka D, Takeuchi S, et al. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8. Br J Dermatol. 2015;172:272–5.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Robertson AD, Wu J, et al. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003. JAMA Dermatol. 2013;149:1180–2011.
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC, de Hoop D, de Korte J, et al. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology. 2000;200:292–8.
   PubMed Web of Science ®Google Scholar
• Eastman WJ, Malahias S, Delconte J, DiBenedetti D. Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis. 2014;94:46–53.
   PubMed Web of Science ®Google Scholar
• Zschocke I, Mrowietz U, Lotzin A, et al. Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ). Arch Dermatol Res. 2014;306:287–97.
   PubMed Web of Science ®Google Scholar
• Feldman SR. Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials. JAMA Dermatol. 2013;149:490–1.
   PubMed Web of Science ®Google Scholar
• Koehler AM, Maibach HI. Electronic monitoring in medication adherence measurement. Implications for dermatology. Am J Clin Dermatol. 2001;2:7–12.
   PubMedGoogle Scholar
• Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51:212–16.
   PubMed Web of Science ®Google Scholar
• Feldman SR, Camacho FT, Krejci-Manwaring J, et al. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57:81–3.
   PubMed Web of Science ®Google Scholar
• van de Kerkhof PC, Franssen M, de La Brassine M, Kuipers M. Calcipotriol cream in the morning and ointment in the evening: a novel regimen to improve compliance. J Dermatol Treat. 2001;12:75–9.
   PubMed Web of Science ®Google Scholar
• Halioua B, Maury Le Breton A, de Fontaubert A, et al. Treatment refusal among patients with psoriasis. J Dermatol Treat. 2015;26:396–400.
   PubMed Web of Science ®Google Scholar
• Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280–8.
   PubMed Web of Science ®Google Scholar
• Joseph-Williams N, Elwyn G, Edwards A. Knowledge is not power for patients: a systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making. Patient Educ Counsel. 2014;94:291–309.
   PubMed Web of Science ®Google Scholar
• Feldman SR. A novel approach to increasing patient outcomes and adherence. J Drugs Dermatol. 2012;11:14–17.
   Web of Science ®Google Scholar
• Vrijens B, Urquhart J, White D. Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev Clin Pharmacol. 2014;7:633–44.
   PubMed Web of Science ®Google Scholar
• Greenlaw SM, Yentzer BA, O’Neill JL, et al. Assessing adherence to dermatology treatments: a review of self-report and electronic measures. Skin Res Technol. 2010;16:253–8.
   PubMed Web of Science ®Google Scholar
• Fleischer AB, Feldman SR, Dekle CL. The SAPASI is valid and responsive to psoriasis disease severity changes in a multi‐center clinical trial. J Dermatol. 1999;26:210–15.
   PubMedGoogle Scholar
• Zachariae R, Zachariae C, Ibsen H, et al. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol. 2000;80:272–6.
   PubMed Web of Science ®Google Scholar